Virginia Commonwealth University (VCU) is a clinical research site located in Richmond, Virginia, United States 23219.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Virginia Commonwealth University (VCU) has participated in 12 clinical trials with 8 currently active.
Therapeutic areas: Sickle Cell Disease, Aortic Aneurysm, Abdominal, Myotonic Dystrophy Type 1 (DM1).
Sponsors: Genetix Biotherapeutics Inc., Rijnstate Hospital, Dyne Therapeutics.
Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Virginia Commonwealth University (VCU) has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Commonwealth University (VCU) has 12 clinical trials on record, with 8 currently active. Their work covers Sickle Cell Disease, Aortic Aneurysm, Abdominal, Myotonic Dystrophy Type 1 (DM1).
Yes — Virginia Commonwealth University (VCU) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.